U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07364851) titled 'A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers' on Jan. 06.

Brief Summary: Safety and pharmacokinetic characteristics evaluation of DW4421-T1 and DW4421S-T1

Study Start Date: March 06

Study Type: INTERVENTIONAL

Condition: Healthy Adult Volunteer

Intervention: DRUG: DW4421-T1

DW4421-T1 or DW4421S-T1

DRUG: DW4421S-T1

DW4421-T1 or DW4421S-T1

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Daewon Pharmaceutical Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....